• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to letter to the editor on "The prevalence and influencing factors of frailty in patients with chronic kidney disease: a systematic review and meta-analysis".

作者信息

Li Bo-Han, Wu Guo-Cui

机构信息

School of Nursing, Anhui Medical University, 15 Feicui Road, Hefei, 230032, Anhui, China.

出版信息

Int Urol Nephrol. 2024 Apr;56(4):1513-1514. doi: 10.1007/s11255-023-03835-3. Epub 2023 Oct 13.

DOI:10.1007/s11255-023-03835-3
PMID:37831386
Abstract
摘要

相似文献

1
Response to letter to the editor on "The prevalence and influencing factors of frailty in patients with chronic kidney disease: a systematic review and meta-analysis".对致编辑信的回复：“慢性肾脏病患者衰弱的患病率及影响因素：一项系统评价与荟萃分析”
Int Urol Nephrol. 2024 Apr;56(4):1513-1514. doi: 10.1007/s11255-023-03835-3. Epub 2023 Oct 13.
2
Comment on "The prevalence and influencing factors of frailty in patients with chronic kidney disease: a systematic review and meta-analysis".关于“慢性肾脏病患者衰弱的患病率及影响因素：一项系统评价和荟萃分析”的评论
Int Urol Nephrol. 2024 Apr;56(4):1511-1512. doi: 10.1007/s11255-023-03834-4. Epub 2023 Oct 6.
3
Letter to the Editor: prevalence and associated factors of frailty in patients with chronic kidney disease: a cross-sectional analysis of PEAKING study.致编辑的信：慢性肾脏病患者衰弱的患病率及相关因素：PEAKING研究的横断面分析
Int Urol Nephrol. 2024 Mar;56(3):1201-1202. doi: 10.1007/s11255-023-03780-1. Epub 2023 Sep 7.
4
The prevalence and influencing factors of frailty in patients with chronic kidney disease: a systematic review and meta-analysis.慢性肾脏病患者衰弱的患病率及影响因素：系统评价和荟萃分析。
Int Urol Nephrol. 2024 Feb;56(2):767-779. doi: 10.1007/s11255-023-03739-2. Epub 2023 Aug 14.
5
Letter to the editor regarding 'A systemic review and meta-analysis on the efficacy and safety of ferumoxytol for anemia in chronic kidney disease patients'.致编辑的信：关于“慢性肾脏病患者使用铁羧麦芽糖治疗贫血的疗效和安全性的系统评价与荟萃分析”
Ren Fail. 2023 Dec;45(1):2153065. doi: 10.1080/0886022X.2022.2153065.
6
Comment on "Prevalence and associated factors of frailty in patients with chronic kidney disease: a cross‑sectional analysis of PEAKING study".关于“慢性肾脏病患者衰弱的患病率及相关因素：PEAKING研究的横断面分析”的评论
Int Urol Nephrol. 2024 Mar;56(3):1203-1204. doi: 10.1007/s11255-023-03778-9. Epub 2023 Sep 9.
7
Prevalence of physical frailty and impact on survival in patients with chronic kidney disease: a systematic review and meta-analysis.慢性肾脏病患者身体虚弱的流行率及其对生存的影响：系统评价和荟萃分析。
BMC Nephrol. 2023 Sep 3;24(1):258. doi: 10.1186/s12882-023-03303-1.
8
Prevalence of unrecognized or "silent" myocardial ischemia in chronic kidney disease patients: Protocol for a systematic review and meta-analysis.慢性肾脏病患者无症状或“沉默性”心肌缺血的患病率：系统评价和荟萃分析方案。
PLoS One. 2021 Sep 2;16(9):e0256934. doi: 10.1371/journal.pone.0256934. eCollection 2021.
9
[Frailty and chronic kidney disease - the real problem of modern nephrology: A review].[衰弱与慢性肾脏病——现代肾脏病学的真正问题：综述]
Ter Arkh. 2023 Aug 17;95(6):516-520. doi: 10.26442/00403660.2023.06.202270.
10
Prevalence and associated factors of frailty in patients with chronic kidney disease: a cross-sectional analysis of PEAKING study.慢性肾脏病患者衰弱的患病率及相关因素：PEAKING 研究的横断面分析。
Int Urol Nephrol. 2024 Feb;56(2):751-758. doi: 10.1007/s11255-023-03720-z. Epub 2023 Aug 9.

本文引用的文献

1
Characterization of gut microbiota in patients with stage 3-4 chronic kidney disease: a retrospective cohort study.3-4 期慢性肾脏病患者肠道微生物群特征：一项回顾性队列研究。
Int Urol Nephrol. 2024 May;56(5):1751-1762. doi: 10.1007/s11255-023-03893-7. Epub 2023 Dec 12.
2
Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study.系统评价文献检索的最佳数据库组合：一项前瞻性探索性研究。
Syst Rev. 2017 Dec 6;6(1):245. doi: 10.1186/s13643-017-0644-y.
3
Individual Frailty Components and Mortality in Kidney Transplant Recipients.
肾移植受者的个体衰弱成分与死亡率
Transplantation. 2017 Sep;101(9):2126-2132. doi: 10.1097/TP.0000000000001546.
4
Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis.衰弱作为一个新的预测因素，可以预测所有年龄段接受血液透析个体的死亡率和住院率。
J Am Geriatr Soc. 2013 Jun;61(6):896-901. doi: 10.1111/jgs.12266. Epub 2013 May 27.
5
A prospective study of frailty in nephrology-referred patients with CKD.肾脏病学转诊的 CKD 患者衰弱的前瞻性研究。
Am J Kidney Dis. 2012 Dec;60(6):912-21. doi: 10.1053/j.ajkd.2012.05.017. Epub 2012 Jul 7.
6
Frailty, dialysis initiation, and mortality in end-stage renal disease.终末期肾病中的衰弱、透析起始与死亡率
Arch Intern Med. 2012 Jul 23;172(14):1071-7. doi: 10.1001/archinternmed.2012.3020.
7
Significance of frailty among dialysis patients.透析患者中衰弱的意义。
J Am Soc Nephrol. 2007 Nov;18(11):2960-7. doi: 10.1681/ASN.2007020221. Epub 2007 Oct 17.